Press Release By Cannara Biotech Inc. 167 Views

Cannara Biotech Secures Conditional Approval to List on the TSX Exchange

MONTREAL, March 11, 2021 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated Quebec-based producer of premium-grade indoor cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that its application to list on the TSX Venture Exchange (TSXV) has received conditional approval.  The conditional approval marks an important step towards Cannara's goal of building out its operational foundation in 2021 while firmly ensconcing itself as a market leader in the cannabis industry.

"Cannara marched into 2021 with a positive trajectory marked by key milestones," said Zohar Krivorot, President and CEO of Cannara. "We recently received our Health Canada licence, permitting us to sell dried cannabis products to provincial retail distributors, and subsequently enjoyed a successful retail market debut. We are pleased that our commitment to provide consumers with premium-grade cannabis at a reasonable price culminates today with our imminent listing on the TSXV, which will provide our business with greater market visibility and enhanced liquidity for our shareholders as we look ahead to a year of significant growth."

"Our imminent listing on the TSXV solidifies our position as a respected and successful licensed producer in the Canadian cannabis industry," said Nicholas Sosiak, Chief Financial Officer. "We look forward to advancing our strategy and maximizing shareholder value in the coming year, bolstered by the unique capabilities that our impressive product pipeline, competitive platform, state-of-the-art facility and best-in-class people bring to bear."

The TSXV conditional listing approval also coincides with the appointment of Nicholas Sosiak, CPA, CA to Chief Financial Officer and the debut of Cannara's brand portfolio in Quebec. Nicholas Sosiak, who previously served as Cannara's Senior Vice-President of Finance and Operations and subsequently as Interim Chief Financial Officer, has been with Cannara since April 2019.

"Nicholas not only brings a wealth of experience in the financial sector to the Cannara team, but he also has true passion and in-depth understanding of the cannabis industry," continued Zohar Krivorot, "His unique skillset is a boon for our business, and we look forward to continuing our capture of market share in Quebec and across Canada."

Cannara's retail market debut took place in late February and marked an important step forward in commercial revenue generation for the Company while also affirming its reputation as a best-in-class licensed producer in Quebec and Canada. The Company's three flagship brands in Quebec – Tribal, Nugz and Orchid CBD – have been well-received by consumers in Quebec, selling out most of the inventory in a matter of days.



Comments

There are 0 comments on this post

Leave A Comment